The outcomes of juvenile idiopathic arthritis in children managed with contemporary treatments: results from the ReACCh-Out cohort
…, AM Huber, N Shiff, G Boire, R Scuccimarri… - Annals of the …, 2015 - ard.bmj.com
Objective To describe clinical outcomes of juvenile idiopathic arthritis (JIA) in a prospective
inception cohort of children managed with contemporary treatments. Methods Children newly …
inception cohort of children managed with contemporary treatments. Methods Children newly …
Incident vertebral fractures among children with rheumatic disorders 12 months after glucocorticoid initiation: a national observational study
…, AM Huber, DA Cabral, R Scuccimarri… - Arthritis care & …, 2012 - Wiley Online Library
Objective To determine the frequency of incident vertebral fractures (IVF) 12 months after
glucocorticoid (GC) initiation in children with rheumatic diseases and to identify children at …
glucocorticoid (GC) initiation in children with rheumatic diseases and to identify children at …
Consensus treatments for moderate juvenile dermatomyositis: beyond the first two months. Results of the second Childhood Arthritis and Rheumatology Research …
…, B Shaham, H Schmeling, R Scuccimarri… - Arthritis care & …, 2012 - Wiley Online Library
Objective To use consensus methods and the considerable expertise contained within the
Childhood Arthritis and Rheumatology Research Alliance (CARRA) organization to extend …
Childhood Arthritis and Rheumatology Research Alliance (CARRA) organization to extend …
Early outcomes and improvement of patients with juvenile idiopathic arthritis enrolled in a Canadian multicenter inception cohort
…, N Johnson, J Dorval, R Scuccimarri… - Arthritis care & …, 2010 - Wiley Online Library
Objective To determine early outcomes and early improvements in a prospective inception
cohort of children with juvenile idiopathic arthritis (JIA) treated with current standard therapies…
cohort of children with juvenile idiopathic arthritis (JIA) treated with current standard therapies…
Treatment approaches to juvenile dermatomyositis (JDM) across North America: the childhood arthritis and rheumatology research alliance (CARRA) JDM treatment …
…, S Ota, C Pilkington, AM Reed, R Scuccimarri… - The Journal of …, 2010 - jrheum.org
Objective. There are a number of different approaches to the initial treatment of juvenile
dermatomyositis (JDM). We assessed the therapeutic approaches of North American pediatric …
dermatomyositis (JDM). We assessed the therapeutic approaches of North American pediatric …
Incident vertebral fractures and risk factors in the first three years following glucocorticoid initiation among pediatric patients with rheumatic disorders
Vertebral fractures are an important yet underrecognized manifestation of osteoporosis in
children with chronic, glucocorticoid‐treated illnesses. Our goal was to determine the …
children with chronic, glucocorticoid‐treated illnesses. Our goal was to determine the …
The risk and nature of flares in juvenile idiopathic arthritis: results from the ReACCh-Out cohort
…, DM Levy, E Stringer, R Scuccimarri… - Annals of the …, 2016 - ard.bmj.com
Objective To describe probabilities and characteristics of disease flares in children with juvenile
idiopathic arthritis (JIA) and to identify clinical features associated with an increased risk …
idiopathic arthritis (JIA) and to identify clinical features associated with an increased risk …
Predictors of early inactive disease in a juvenile idiopathic arthritis cohort: results of a Canadian multicenter, prospective inception cohort study
…, AM Huber, P Miettunen, R Scuccimarri… - Arthritis Care & …, 2009 - Wiley Online Library
Objective To determine early predictors of 6‐month outcomes in a prospective cohort of
patients with juvenile idiopathic arthritis (JIA). Methods Patients selected were those enrolled in …
patients with juvenile idiopathic arthritis (JIA). Methods Patients selected were those enrolled in …
Immunoglobulin, glucocorticoid, or combination therapy for multisystem inflammatory syndrome in children: a propensity-weighted cohort study
…, CM Biggs, A Lopez, R Scuccimarri… - The Lancet …, 2023 - thelancet.com
Background Multisystem inflammatory syndrome in children (MIS-C), a hyperinflammatory
condition associated with SARS-CoV-2 infection, has emerged as a serious illness in children …
condition associated with SARS-CoV-2 infection, has emerged as a serious illness in children …
Aspirin dose and prevention of coronary abnormalities in Kawasaki disease
…, BW McCrindle, DG Human, R Scuccimarri - …, 2017 - publications.aap.org
BACKGROUND: Acetylsalicylic acid (ASA) is part of the recommended treatment of Kawasaki
disease (KD). Controversies remain regarding the optimal dose of ASA to be used. We …
disease (KD). Controversies remain regarding the optimal dose of ASA to be used. We …